Biotech · San Francisco, CA · Founded 2024 · Privately Held (backing)
Developer of an AI-based molecular interactions platform designed for molecular structure prediction that performs state-of-the-art across tasks relevant to drug discovery. Chai Discovery is based in San Francisco, CA and was founded in 2024. Its last reported valuation was $1.3 billion in Dec 2025. It has raised $230 million across 4 recorded rounds; the latest was a $400 million Series C in Jul 2026.
Last reported valuation
$1.3B
Oct 2026
Priced at
—
Total raised
$230.0M
Last round
Series C
Jul 2026
No prints on record
No secondary trades in Chai Discovery shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Chai Discovery with a free account
·The complete investor list: 21 names
·Watch Chai Discovery: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Chai Discovery stock.
